Evidence map›Paper›PMID 25541945›Full record

ArticlePloS one2014

Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function.

Robby Markwart, Stephanie A Condotta, Robert P Requardt, Farina Borken, Katja Schubert, Cynthia Weigel, Michael Bauer, Thomas S Griffith, Martin Förster, Frank M Brunkhorst and 2 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Lymphopenia in sepsis: a narrative review.Critical care (London, England) · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Robby MarkwartIntegrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Stephanie A CondottaDept. of Pathology, University of Iowa, Iowa City, Iowa, United States of America.
Robert P RequardtIntegrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Farina BorkenIntegrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Katja SchubertIntegrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Cynthia WeigelIntegrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Michael BauerIntegrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany; Dept. for Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Thomas S GriffithMinneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota, United States of America; Center for Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Martin FörsterClinic of Internal Medicine I, Jena University Hospital, Jena, Germany.
Frank M BrunkhorstIntegrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany; Center for Clinical Studies, Jena University Hospital, Jena, Germany.
Vladimir P BadovinacDept. of Pathology, University of Iowa, Iowa City, Iowa, United States of America.
Ignacio RubioIntegrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany; Institute of Molecular Cell Biology, Center for Molecular Biomedicine, Jena University Hospital, Jena, Germany.

Funding

Memory CD8 T cell localization and protection from influenzaR01AI114543 · NIAID · UNIVERSITY OF IOWA · PI BADOVINAC, VLADIMIR P, HARTY, JOHN T · 2015 to 2024
$4.4M
Memory CD8 T Cell Responses After Multiple Antigen EncountersR01AI083286 · NIAID · UNIVERSITY OF IOWA · PI BADOVINAC, VLADIMIR P · 2009 to 2012
$1.5M
Using microbially-experienced mice to study the innate immune response in sepsisI01BX001324 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI GRIFFITH, THOMAS S · 2013 to 2025
–
BLRD VA I01 BX001324NIAID NIH HHS AI114543NIAID NIH HHS AI83286NIAID NIH HHS R01 AI083286NIAID NIH HHS R01 AI114543
6 · The paper itself

Abstract

Sepsis describes the life-threatening systemic inflammatory response (SIRS) of an organism to an infection and is the leading cause of mortality on intensive care units (ICU) worldwide. An acute episode of sepsis is characterized by the extensive release of cytokines and other mediators resulting in a dysregulated immune response leading to organ damage and/or death. This initial pro-inflammatory burst often transits into a state of immune suppression characterised by loss of immune cells and T-cell dysfunction at later disease stages in sepsis survivors. However, despite these appreciations, the precise nature of the evoked defect in T-cell immunity in post-acute phases of SIRS remains unknown. Here we present an in-depth functional analysis of T-cell function in post-acute SIRS/sepsis. We document that T-cell function is not compromised on a per cell basis in experimental rodent models of infection-free SIRS (LPS or CpG) or septic peritonitis. Transgenic antigen-specific T-cells feature an unaltered cytokine response if challenged in vivo and ex vivo with cognate antigens. Isolated CD4(+)/CD8(+) T-cells from post-acute septic animals do not exhibit defects in T-cell receptor-mediated activation at the the level of receptor-proximal signalling, activation marker upregulation or expansion. However, SIRS/sepsis induced transient lymphopenia and gave rise to an environment of immune attenuation at post acute disease stages. Thus, systemic inflammation has an acute impact on T-cell numbers and adaptive immunity, but does not cause major cell-autonomous enduring functional defects in T-cells.

Indexed as

Adaptive ImmunityAnimalsCytokinesDisease Models, AnimalHumansImmunosuppression TherapyInflammationLymphopeniaMiceMice, Inbred C57BLMice, TransgenicReceptors, Antigen, T-CellSepsisT-LymphocytesCytokinesReceptors, Antigen, T-Cell

Identifiers

PMID25541945
PMCPMC4277344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.